Search
for
Sort by
Research 541–570 of 1000+
- 25 years of ERβ: a personal journey
- Post-finasteride syndrome – does it really exist?
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Examination of Fluconazole-Induced Alopecia in an Animal Model and Human Cohort
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Acne
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- The serum evaluation of sex hormones including DHEAs, DHT, testosterone in oral lichen planus patients
- Hormonal Therapy for Acne
- Skin as a Window to Endocrine Dysfunction: Dermatological and Metabolic Interactions in Polycystic Ovary Syndrome
- Effect of mesenchymal stem cells on reducing melanin levels in response to UV radiation in male C57BL/6 mice
- Dehydrogenase, Cortisol, Dopamine, Zinc, and Vitamin D3 in Iraqi Patients with Polycystic Ovary Syndrome
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- Prostate Specific Antigen as Predictive Factor for Androgenemia in Women
- Skin melanocytes: biology and development
- Repurposing of approved cardiovascular drugs
- Polycystic Ovary Syndrome: Diagnosis and Treatment
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Post-finasteride syndrome
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Assessment of Vitamin D Level in Patients of Alopecia Areata
- A Screening Study on Dermatoses in Pregnancy
- Anti-inflammatory and anti-hyperplastic effect of Bazhengsan in a male rat model of chronic nonbacterial prostatitis
- Diagnosis and treatments of hirsutism: where are we?
- A Comparative Analysis of Serum Irisin Levels and Body Composition Indices in Women With and Without Polycystic Ovary Syndrome (PCOS)
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Cutaneous drug reactions
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia